

SPOREs are designed to enable the rapid and efficient movement of basic scientific findings into clinical settings, as well as to determine the biological basis for observations made in individuals with cancer or in populations at risk for cancer. SPORE grants involve both basic and clinical/applied scientists working together and support projects that will result in new and diverse approaches to the prevention, early detection, diagnosis and treatment of human cancers.Įach SPORE is focused on a specific organ site, such as breast or lung cancer, a group of highly related cancers, such as gastrointestinal cancers and sarcomas, or a common pathway or theme that ties together the cancers under study. TRP is the home of the SPOREs - the Specialized Programs of Research Excellence - a cornerstone of NCI's efforts to promote collaborative, interdisciplinary translational cancer research. Supporting additional grant mechanisms for translational research.

Facilitating the cross-fertilization of ideas, leveraging resources, and ensuring access of resources to projects and investigators to bring discoveries from the laboratory to the clinic in the most efficient manner.Promoting research in high incidence as well as rare cancers.Encouraging a multidirectional approach to translational research.Supporting the Specialized Programs of Research Excellence (SPOREs) to translate novel scientific discoveries into clinical testing, including early-phase clinical trials.TRP uses advances in basic sciences to develop new approaches for the prevention, diagnosis, and treatment of cancer by fostering interdisciplinary investigations and coordinating the resources of NCI with those of academia, industry, and nonprofit organizations and foundations. The Translational Research Program (TRP) is committed to reducing cancer incidence and mortality and improving survival and quality of life for cancer patients. Welcome to the Translational Research Program (TRP)
